1. ScholarBank@NUS

Alexandre Chan

rp02336

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Alexandre Chan
Variants
Chan, A.
Chan, Alexandre
Chan A
 
Main Affiliation
 
Faculty
 
Email
gmschal@nus.edu.sg
 

Publications

Refined By:
Type:  Review

Results 1-19 of 19 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
1Jul-2012An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivorsCheung, Y.T.; Tan, E.H.-J.; Chan, A. 
2Oct-2013Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study GroupWong, R.K.S.; Bensadoun, R.-J.; Boers-Doets, C.B.; Bryce, J.; Chan, A. ; Epstein, J.B.; Eaby-Sandy, B.; Lacouture, M.E.
3Aug-2011Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicitiesLacouture, M.E.; Anadkat, M.J.; Bensadoun, R.-J.; Bryce, J.; Chan, A. ; Epstein, J.B.; Eaby-Sandy, B.; Murphy, B.A.
4Jan-2011Clinically relevant drug interactions between anticancer drugs and psychotropic agentsYap, K.Y.-L.; Tay, W.L.; Chui, W.K. ; Chan, A. 
5Jan-2010Clinically-relevant chemotherapy interactions with complementary and alternative medicines in patients with cancerYap, K.Y.-L.; See, C.S.; Chan, A. 
6Feb-2012Clinicallyrelevant anticancer-antidepressant drug interactionsChan, A. ; Rong De Ng, T.; Yi-Lwern Yap, K.
7Oct-2012Conservative management of L-asparaginase-induced hypertriglyceridemia in an adult patient: A case report and review of the literatureSeah, J.; Lin, K.; Tai, D.; Lim, S.T.; Chan, A. 
8Jan-2012Dosing modifications of targeted cancer therapies in patients with special needs: Evidence and controversiesNg, T.; Chan, A. 
9Oct-2009Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitorsEng, H.T.; Chan, A. 
102018Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: A systematic reviewToh Y.L.; Ng T.; Tan M.; Tan A.; Chan A. 
11Dec-2011Impact of erythropoiesis-stimulating agent prescribing at an Asian cancer center, after release of safety advisoriesChan, Q.; Chan, A. 
12Oct-2009Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapyYap, K.Y.-L.; Chan, A. ; Chui, W.K. 
132015Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: Current understanding, challenges and recommendationsTeo Y.L ; Ho H.K ; Chan A 
14Jul-2012Neuro-cognitive impairment in breast cancer patients: Pharmacological considerationsCheung, Y.T.; Chui, W.K. ; Chan, A. 
15Dec-2011Polypharmacy in elderly patients with cancer: Clinical implications and managementLees, J.; Chan, A. 
16Apr-2013Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysisTeo, Y.L.; Ho, H.K. ; Chan, A. 
172020Role of exosomes in cancer-related cognitive impairmentKoh, Y.Q.; Tan, C.J.; Toh, Y.L.; Sze, S.K.; Ho, H.K. ; Limoli, C.L.; Chan, A. 
18Apr-2007Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patientsChan, A. ; Iannucci, A.; Dager, W.E.
19Jan-2014Vascular endothelial growth factor inhibitors and cognitive impairment: Evidence and controversiesNg, T.; Cheung, Y.T.; Ng, Q.S.; Ho, H.K. ; Chan, A.